Fenofibrate Tablet
Product Images NDC 42385-950

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 42385-950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D9f3d953 039d 4d3c A665 53db00e0ddf8 01

Chemical structure diagram of fenofibrate, showing the molecular arrangement including chlorophenyl, carbonyl, and ester functional groups characteristic of the active ingredient fenofibrate.*

FDA Label Image

D9f3d953 039d 4d3c A665 53db00e0ddf8 02

Fenofibrate Tablets, USP 48 mg oral tablet label from Laurus Labs Limited. The label includes storage instructions, manufacturer details, and a package count of 90 tablets. It states the product is prescription only and includes warnings about moisture protection and child resistance.*

FDA Label Image

D9f3d953 039d 4d3c A665 53db00e0ddf8 03

Fenofibrate Tablets, USP 145 mg oral tablet label with 90 count by Laurus Labs Limited. The label includes storage instructions of 20 to 25 degrees Celsius, child-resistant packaging notice, and manufacturer details of Laurus Generics Inc. and Graviti Pharmaceuticals Pvt. Ltd., India. It also notes to see package insert for full prescribing information and includes the NDC 42385-951-90.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.